Key facts
- AISAP’s last known valuation is $22.5M (Dec 2023).
- It has raised $26.0M; the latest was Accelerator/Incubator ($13.0M) in Jun 2025.
- Notable investors include ARC Innovation Center, Harel Insurance Investments & Financial Services, Interreg North-West Europe, Padeh Poriya Hospital, RISE (Accelerator) — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for AISAP
- ·The full record, as it builds
Funding rounds
No funding rounds for AISAP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AISAP
Developer of an artificial intelligence-powered point-of-care ultrasound system designed to empower clinicians with immediate diagnostics. The company offers a platform that streamlines ultrasound workflows and provides AI-driven interpretations by utilizing deep convolutional neural networks to analyze ultrasound images in real time, enabling medical professionals to make better clinical decisions and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Ramat Gan, Israel
- Founded
- 2022
- Employees
- 37
- Website
- aisap.ai/
- Ownership
- Privately Held (backing)
AISAP doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AISAP shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AISAP in its N-PORT filings yet. We sweep new filings monthly.